Catalyst Wire Dossier Catalyst Wire Dossier

Rifaximin SSD tablets

rifaximin · Bausch Health Americas, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Rifaximin SSD tablets, covering 2019-10-23 to 2023-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Rifaximin Soluble Solid Dispersion (SSD) Tablets Plus Lactulose for the Treatment of Overt Hepatic Encephalopathy (OHE) [Phase 2]

See pricing